FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2549002080> ?p ?o ?g. }

• W2549002080 endingPage "13" @default.
• W2549002080 startingPage "3" @default.
• W2549002080 abstract "Long-acting injectable antipsychotic therapies may offer benefits over oral antipsychotics in patients with schizophrenia. This study aimed to explore the safety, tolerability, and treatment response of paliperidone palmitate once-monthly in non-acute but symptomatic adult patients switched from previously unsuccessful monotherapy with frequently used oral atypical antipsychotics. This was a post hoc analysis of a prospective, interventional, single-arm, international, multicenter, open-label, 6-month study. The patients (N = 472) were switched to paliperidone palmitate once-monthly (PP1M) from daily oral treatment with either aripiprazole (n = 46), olanzapine (n = 87), paliperidone extended-release (n = 104), quetiapine (n = 44), or risperidone (n = 191). In all groups, mean Positive and Negative Syndrome Scale total (p < 0.0001) and Clinical Global Impression-Severity scores improved significantly (p = 0.0004 to p < 0.0001). An improvement of ≥50 % in the Positive and Negative Syndrome Scale total score was observed in 21.7 % (aripiprazole), 29.9 % (olanzapine), 29.8 % (paliperidone extended-release), 27.3 % (quetiapine), and 37.2 % (risperidone) of patients. The patients showed significant improvements in the Personal and Social Performance score (aripiprazole p = 0.0409, all others p ≤ 0.0015); Mini International Classification of Functionality, Disability and Health Rating for Activity and Participation Disorders in Psychological Illnesses total scores (all p < 0.01); and Treatment Satisfaction Questionnaire for Medication Global Satisfaction score (olanzapine and risperidone p < 0.0001, quetiapine p = 0.0465, paliperidone extended-release p = 0.0571, aripiprazole p = NS). Paliperidone palmitate once-monthly was well tolerated, presenting no new safety signals. These data illustrate that stable, non-acute but symptomatic patients on oral antipsychotic monotherapy may show clinically meaningful improvement of symptoms, functioning, and treatment satisfaction after direct transition to PP1M. The findings are limited by the naturalistic study design; thus, further studies are required to confirm the current findings." @default.
• W2549002080 created "2016-11-11" @default.
• W2549002080 creator A5024364031 @default.
• W2549002080 creator A5053174968 @default.
• W2549002080 creator A5058880525 @default.
• W2549002080 creator A5063425328 @default.
• W2549002080 creator A5068132580 @default.
• W2549002080 creator A5068311717 @default.
• W2549002080 creator A5073403274 @default.
• W2549002080 creator A5074778675 @default.
• W2549002080 creator A5084564551 @default.
• W2549002080 creator A5090231742 @default.
• W2549002080 date "2016-11-05" @default.
• W2549002080 modified "2023-10-16" @default.
• W2549002080 title "Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study" @default.
• W2549002080 cites W1604217211 @default.
• W2549002080 cites W1763953748 @default.
• W2549002080 cites W1906307956 @default.
• W2549002080 cites W1963580478 @default.
• W2549002080 cites W1969486406 @default.
• W2549002080 cites W1977536404 @default.
• W2549002080 cites W1986462877 @default.
• W2549002080 cites W1988479995 @default.
• W2549002080 cites W1991152094 @default.
• W2549002080 cites W1992857340 @default.
• W2549002080 cites W1994817144 @default.
• W2549002080 cites W1995219138 @default.
• W2549002080 cites W2009832071 @default.
• W2549002080 cites W2013280864 @default.
• W2549002080 cites W2016968691 @default.
• W2549002080 cites W2022592863 @default.
• W2549002080 cites W2029068959 @default.
• W2549002080 cites W2041474698 @default.
• W2549002080 cites W2051386775 @default.
• W2549002080 cites W2056319805 @default.
• W2549002080 cites W2057464084 @default.
• W2549002080 cites W2058867975 @default.
• W2549002080 cites W2061331619 @default.
• W2549002080 cites W2061525750 @default.
• W2549002080 cites W2061901099 @default.
• W2549002080 cites W2072667216 @default.
• W2549002080 cites W2074863161 @default.
• W2549002080 cites W2085145222 @default.
• W2549002080 cites W2088866491 @default.
• W2549002080 cites W2097250781 @default.
• W2549002080 cites W2107201157 @default.
• W2549002080 cites W2111694736 @default.
• W2549002080 cites W2127124245 @default.
• W2549002080 cites W2143285031 @default.
• W2549002080 cites W2144317224 @default.
• W2549002080 cites W2148638523 @default.
• W2549002080 cites W2154849243 @default.
• W2549002080 cites W2159039084 @default.
• W2549002080 cites W2159155203 @default.
• W2549002080 cites W2160096204 @default.
• W2549002080 cites W2160409159 @default.
• W2549002080 cites W2161270807 @default.
• W2549002080 cites W2169092436 @default.
• W2549002080 cites W2170433240 @default.
• W2549002080 cites W2171019609 @default.
• W2549002080 cites W2239441925 @default.
• W2549002080 cites W4253924106 @default.
• W2549002080 cites W4320800471 @default.
• W2549002080 doi "https://doi.org/10.1007/s00213-016-4445-0" @default.
• W2549002080 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5203852" @default.
• W2549002080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27815602" @default.
• W2549002080 hasPublicationYear "2016" @default.
• W2549002080 type Work @default.
• W2549002080 sameAs 2549002080 @default.
• W2549002080 citedByCount "11" @default.
• W2549002080 countsByYear W25490020802016 @default.
• W2549002080 countsByYear W25490020802018 @default.
• W2549002080 countsByYear W25490020802019 @default.
• W2549002080 countsByYear W25490020802020 @default.
• W2549002080 countsByYear W25490020802021 @default.
• W2549002080 countsByYear W25490020802023 @default.
• W2549002080 crossrefType "journal-article" @default.
• W2549002080 hasAuthorship W2549002080A5024364031 @default.
• W2549002080 hasAuthorship W2549002080A5053174968 @default.
• W2549002080 hasAuthorship W2549002080A5058880525 @default.
• W2549002080 hasAuthorship W2549002080A5063425328 @default.
• W2549002080 hasAuthorship W2549002080A5068132580 @default.
• W2549002080 hasAuthorship W2549002080A5068311717 @default.
• W2549002080 hasAuthorship W2549002080A5073403274 @default.
• W2549002080 hasAuthorship W2549002080A5074778675 @default.
• W2549002080 hasAuthorship W2549002080A5084564551 @default.
• W2549002080 hasAuthorship W2549002080A5090231742 @default.
• W2549002080 hasBestOaLocation W25490020801 @default.
• W2549002080 hasConcept C118552586 @default.
• W2549002080 hasConcept C126322002 @default.
• W2549002080 hasConcept C142724271 @default.
• W2549002080 hasConcept C15744967 @default.
• W2549002080 hasConcept C197934379 @default.
• W2549002080 hasConcept C204787440 @default.
• W2549002080 hasConcept C27081682 @default.
• W2549002080 hasConcept C2776000289 @default.
• W2549002080 hasConcept C2776412080 @default.
• W2549002080 hasConcept C2776619155 @default.

• next